Tolcapone (Compound)

Synonyms:Tolcapone, 134308-13-7, Tasmar, Ro 40-7592, 3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone, (3,4-Dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone, Ro-40-7592, (3,4-dihydroxy-5-nitrophenyl)(p-tolyl)methanone, (3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone, Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-, MFCD00866569, Ro-407592, CHEMBL1324, CIF6334OLY, DTXSID3023685, CHEBI:63630, NCGC00181767-01, 3,4-dihydroxy-5-nitro-4'-methylbenzophenone, 4'-methyl-3,4-dihydroxy-5-nitrobenzophenone, DTXCID903685, Talcapone, UNII-CIF6334OLY, Tasmar (TN), CCRIS 7904, CAS-134308-13-7, Tolcapone [USAN:USP:INN:BAN], Tolcapone- Bio-X, TCW, TOLCAPONE [INN], TOLCAPONE [JAN], TOLCAPONE [MI], TOLCAPONE [USAN], TOLCAPONE [VANDF], TOLCAPONE [MART.], 5-(4-methylbenzoyl)-3-nitrobenzene-1,2-diol, TOLCAPONE [USP-RS], TOLCAPONE [WHO-DD], Tolcapone (JAN/USP/INN), SCHEMBL33869, TOLCAPONE [EMA EPAR], MLS006012044, BIDD:GT0032, (3,4-dihydroxy-5-nitro-phenyl)-(p-tolyl)methanone, GTPL6646, TOLCAPONE [ORANGE BOOK], Tolcapone, >=98% (HPLC), Methanone,(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-, TOLCAPONE [USP MONOGRAPH], 3s68, HMS2089K14, HMS3652M17, HMS3715D16, HMS3872F03, HMS3885G18, BCP09156, Tox21_112963, Tox21_302414, 3,4-dihydroxy-4 inverted exclamation mark -methyl-5-nitrobenzophenone, AC-791, BDBM50108877, s4021, AKOS015902328, Tox21_112963_1, AS-7085, CCG-221217, CS-1173, DB00323, KS-1314, NCGC00181767-02, NCGC00181767-03, NCGC00255188-01, BT164481, HY-17406, SMR001614567, SY102278, DB-013561, FT-0631149, SW219511-1, T3856, C07949, D00786, O10068, AB01275441-01, AB01275441_02, (3,4-Dihydroxy-5-nitro-phenyl)-p-tolyl-methanone, EN300-18567526, Q413840, SR-05000001444, Q-201840, SR-05000001444-1, BRD-K10852020-001-01-1, 5-[(4-METHYLPHENYL)CARBONYL]-3-NITROBENZENE-1,2-DIOL, Tolcapone, United States Pharmacopeia (USP) Reference Standard

Pubchem:PUBCHEM:4659569

Id:2669bb38-bc73-5ca8-9b6d-ccebf12d41f1

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Tolcapone's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Tolcapone.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Tolcapone.

Results found

Linked to

	Label	Description
	BRD-K10852020-001-04-5 Substance (Entity type)	A Substance
	tolcapone (8153dd9f-27c7-466c-8aae-6cccf4fb6d45) Collection (Entity type)	Metadatata for tolcapone
	DCSTRUCT ID 02697 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02697; PubChem_CID:4659569, FILE=drugcentral_drug_02697.json)
	Tolcapone positively regulates DNAJA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tolcapone negatively regulates CCL20 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tolcapone in similarity relationship with Oxybutynin Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Bambuterol in similarity relationship with Tolcapone Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	SID11111514 in similarity relationship with Tolcapone Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tolcapone positively regulates ASCL1 Gene Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Tolcapone positively regulates GNAS Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS